CTRI/2023/12/060828
招募中
未知
Improving Survival in Childhood Acute Lymphoblastic Leukemia in India (ISCALL): ICiCLe Implementation Study - ISCA
Cancer Institute0 个研究点目标入组 0 人待定
概览
- 阶段
- 未知
- 干预措施
- 未指定
- 疾病 / 适应症
- 未指定
- 发起方
- Cancer Institute
- 状态
- 招募中
- 最后更新
- 去年
概览
简要总结
暂无简介。
研究者
入排标准
入选标准
- •1\. Newly diagnosed pediatric acute lymphoblastic leukemia (ALL).
排除标准
- •1\. Relapsed or refractory ALL.
- •2\. Mixed\-phenotype acute leukemia.
结局指标
主要结局
未指定
相似试验
Unknown
2 期
Treatment of Newly Diagnosed High Risk Acute Lymphoblastic Leukemia in ChildrenAcute Lymphoblastic LeukemiaChildNCT02339350The Korean Society of Pediatric Hematology Oncology110
已完成
不适用
Prospective cohort study of pediatric acute lymphoblastic leukemia patients treated with Tokyo Children's Cancer Study Group risk stratification TCCSG ALL L09-1603.version1.1Acute Lymphoblastic LeukemiaJPRN-UMIN000003375Tokyo Children's Cancer Study Group400
招募中
不适用
Mercaptopurine Therapeutic Drug Monitoring to Optimize the Maintenance Phase of Childhood ALLAcute Lymphoblastic LeukemiaNCT05811845IRCCS Burlo Garofolo250
已完成
3 期
Treatment of Acute Lymphoblastic Leukemia in ChildrenAcute Lymphoblastic LeukemiaNCT00165178Dana-Farber Cancer Institute498
进行中（未招募）
1 期
Therapy of the Young Adult Acute Lymphoblastic Leukemia (ALL): treatment intensification of the pediatric protocol AIEOP LLA-2000 - GIMEMA LAL 1308Acute Lymphoblastic Leukemia (ALL)MedDRA version: 9.1Level: LLTClassification code 10000844EUCTR2009-016075-30-ITG.I.M.E.M.A. GRUPPO ITALIANO MALATTIE EMATOLOGICHE DELL`ADULTO30